Skip to main content
Premium Trial:

Request an Annual Quote

Rosanne Coppola, Bruce Koepfgen

Premium

Fisher Scientific said this week that it has named Rosanne Coppola and Bruce Koepfgen to the company's board of directors.

Coppola is currently director of M&F Worldwide, and has held several senior management positions at Citicorp, said Fisher Scientific.

Koepfgen is CEO of Oppenheimer Capital. Prior to this, he was president of management consulting firm Koepfgen Company. He also spent 23 years at Salomon Brothers in various executive positions including managing director.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.